<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7404079\results\search\drug\results.xml">
  <result pre="and gastrointestinal tract illnesses [19]. Sirtuins, a family of nicotinamide" exact="adenine" post="dinucleotide (NAD)+ dependent deacetylases, play an important role in"/>
  <result pre="virus-receptor interaction [33]. Promoter hypermethylation downregulates APN gene expression and" exact="azacitidine" post="(5-azaC) induces APN protein expression [34]. In melanoma cells,"/>
  <result pre="to inhibit the activity of 3CLpro including the anti-HIV drug" exact="lopinavir" post="[16]. The structural viral proteins (NP, M, E, and"/>
  <result pre="favipiravir, ribavirin, galidesivir, and its salt form (BCX-4430) targeting RdRp;" exact="ritonavir" post="and darunavir targeting viral proteases (3CLpro or PLpro) in"/>
  <result pre="darunavir targeting viral proteases (3CLpro or PLpro) in addition to" exact="camostat" post="mesylate which is a serine protease inhibitor directly acting"/>
  <result pre="and S protein showed efficacy against SARS-CoV-2 as well as" exact="chloroquine" post="which possesses an antiviral and an anti-inflammatory effect [16]."/>
  <result pre="and depsipeptide [63, 66, 67]. Other potent HDACi such as" exact="vorinostat" post="or suberanilohydroxamic acid (SAHA), belinostat, romidepsin, and panobinostat were"/>
  <result pre="[63, 66, 67]. Other potent HDACi such as vorinostat or" exact="suberanilohydroxamic acid" post="(SAHA), belinostat, romidepsin, and panobinostat were already used for"/>
  <result pre="the contrary, a possible synergism was revealed combining BIX-01294 with" exact="vorinostat" post="and DZNep with vorinostat [71]. BRD4, a chief gene"/>
  <result pre="synergism was revealed combining BIX-01294 with vorinostat and DZNep with" exact="vorinostat" post="[71]. BRD4, a chief gene expression regulator, is involved"/>
  <result pre="NFÎºB pathway [58]. Panobinostat + antivirals or (rapamycin, selumetinib, trametinib)" exact="Belinostat" post="and domatinostat Enhanced TGF-Î² expression [58]. Belinostat or domatinostat"/>
  <result pre="(rapamycin, selumetinib, trametinib) Belinostat and domatinostat Enhanced TGF-Î² expression [58]." exact="Belinostat" post="or domatinostat + antivirals or (rapamycin, selumetinib, trametinib) HKMT"/>
  <result pre="cellular antiviral state and reduced viral yields [57]. DZNep +" exact="vorinostat" post="HKMT G9a BIX-01294 Enhancing antiviral state [57]. BIX-01294 +"/>
  <result pre="vorinostat HKMT G9a BIX-01294 Enhancing antiviral state [57]. BIX-01294 +" exact="vorinostat" post="HMT Suv39H1 Chaetocin Permanent cell cycle arrest and RNA"/>
  <result pre="and TGF-Î² [58]. 5-azadC + antivirals or (rapamycin, selumetinib, trametinib)" exact="Azacitidine" post="Viral mimicry [62]. Azacitidine + antivirals or (rapamycin, selumetinib,"/>
  <result pre="+ antivirals or (rapamycin, selumetinib, trametinib) Azacitidine Viral mimicry [62]." exact="Azacitidine" post="+ antivirals or (rapamycin, selumetinib, trametinib) BET proteins (BRD4)"/>
  <result pre="Besides, 5-azadC induced IL-10 marker and TGF-Î² [58, 70, 93]." exact="Belinostat" post="and domatinostat enhanced the expression of TGF-Î² [58]. Moreover,"/>
  <result pre="were clinically recovered after the administration of remdesivir combined with" exact="chloroquine" post="(CQ) or IFN-Î² due to the significant blockade of"/>
  <result pre="potency of antiviral therapy was achieved after the fusion of" exact="ribavirin" post="and IFN with immunomodulating agents such as intravenous N-acetylcysteine"/>
  <result pre="of ribavirin and IFN with immunomodulating agents such as intravenous" exact="N-acetylcysteine" post="[94]. Few synergistic combinations resulting from a network-based analysis"/>
  <result pre="[94]. Few synergistic combinations resulting from a network-based analysis include" exact="sirolimus" post="and dactinomycin, an approved RNA synthesis inhibitor, target HCoV-associated"/>
  <result pre="combined with other host-targeting molecules such as peroxisome proliferator-activated receptor" exact="alpha" post="(PPAR-Î±) agonists [11]. In a retrospective analysis, ribavirin was"/>
  <result pre="proliferator-activated receptor alpha (PPAR-Î±) agonists [11]. In a retrospective analysis," exact="ribavirin" post="was tested in combination with corticosteroids, immunoglobulins, and/or antibiotics"/>
  <result pre="SARS-CoV; no efficacy and high fatality rates were shown. Since" exact="ribavirin" post="treatment did not improve patient outcome health, Canada stopped"/>
  <result pre="the use of ribavirin. Additional studies tested the activity of" exact="ribavirin" post="jointly with lopinavir against SARS-CoV. Compared to the control"/>
  <result pre="ribavirin. Additional studies tested the activity of ribavirin jointly with" exact="lopinavir" post="against SARS-CoV. Compared to the control groups, confirmed SARS-CoV"/>
  <result pre="consequences. In another retrospective analysis, patients were treated with oral" exact="ribavirin" post="and SC pegylated IFN-Î±2a for 2 weeks. At day"/>
  <result pre="either alfacon-1, a recombinant consensus IFN-Î±, or protease inhibitors and" exact="ribavirin" post="were found to improve patientsâ€™ health [56]. Patients with"/>
  <result pre="Chromatin immuno-precipitation COVID-19 Coronavirus infectious disease 2019 CoVs Coronaviruses CQ" exact="Chloroquine" post="DCs Dendritic cells DDR DNA damage response DENV Dengue"/>
  <result pre="array MyD88 Myeloid differentiation primary response gene 88 NAD Nicotinamide" exact="adenine" post="dinucleotide NP Nucleocapsid Nsp Non-structural proteins ORF Open reading"/>
  <result pre="of International Concern PLpro Papain-like protease PPAR-Î± Peroxisome proliferator-activated receptor" exact="alpha" post="PRR Prorenin receptor P-TEFb Positive transcription elongation factor beta"/>
  <result pre="COVID-19 susceptibility and severity in lupus patientsClin Immunol.202021510841032276140 84.LedfordHCoronavirus breakthrough:" exact="dexamethasone" post="is first drug shown to save livesNature.202058246932546811 85.Horby P,"/>
  <result pre="of coronavirus disease (COVID-19) outbreakJ Autoimmun.202010910243332113704 96.Principi N, Esposito S." exact="Chloroquine" post="or hydroxychloroquine for prophylaxis of COVID-19. Lancet Infect Dis."/>
  <result pre="disease (COVID-19) outbreakJ Autoimmun.202010910243332113704 96.Principi N, Esposito S. Chloroquine or" exact="hydroxychloroquine" post="for prophylaxis of COVID-19. Lancet Infect Dis. 2020;S1473309920302966. 97.SinghAKSinghAShaikhASinghRMisraAChloroquine"/>
  <result pre="for prophylaxis of COVID-19. Lancet Infect Dis. 2020;S1473309920302966. 97.SinghAKSinghAShaikhASinghRMisraAChloroquine and" exact="hydroxychloroquine" post="in the treatment of COVID-19 with or without diabetes:"/>
  <result pre="developing countriesDiabetes Metab Syndr Clin Res Rev.202014241246 98.WangMCaoRZhangLYangXLiuJXuMet al.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 </snippets>
</snippetsTree>
